144 related articles for article (PubMed ID: 28138311)
1. Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study.
Arellano-Orden E; Calero-Acuña C; Cordero JA; Abad-Arranz M; Sánchez-López V; Márquez-Martín E; Ortega-Ruiz F; López-Campos JL
Int J Med Sci; 2017; 14(1):67-74. PubMed ID: 28138311
[No Abstract] [Full Text] [Related]
2. Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD.
Arellano-Orden E; Calero C; López-Ramírez C; Sánchez-López V; López-Villalobos JL; Abad Arranz M; Blanco-Orozco A; Otero-Candelera R; López-Campos JL
Int J Chron Obstruct Pulmon Dis; 2019; 14():1323-1332. PubMed ID: 31417249
[No Abstract] [Full Text] [Related]
3. Determination of inflammatory biomarkers in patients with COPD: a comparison of different assays.
López-Campos JL; Arellano E; Calero C; Delgado A; Márquez E; Cejudo P; Ortega F; Rodríguez-Panadero F; Montes-Worboys A
BMC Med Res Methodol; 2012 Mar; 12():40. PubMed ID: 22463705
[TBL] [Abstract][Full Text] [Related]
4. Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants.
Mithal LB; Palac HL; Yogev R; Ernst LM; Mestan KK
PLoS One; 2017; 12(1):e0168677. PubMed ID: 28045978
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
6. Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
Lazovic B
Med Arch; 2012; 66(3):159-60. PubMed ID: 22822613
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
9. Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD.
Formiga MF; Vital I; Urdaneta G; Masters B; Herrera J; Campos MA; Cahalin LP
Clin Respir J; 2019 Apr; 13(4):247-255. PubMed ID: 30773817
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
11. The utility of serum amyloid A and other acute-phase reactants determination in ambulatory care COVID-19 patients.
Jegorović B; Nikolić A; Milinković N; Ignjatović S; Šipetić-Grujičić S
J Med Biochem; 2023 Aug; 42(3):492-504. PubMed ID: 37790210
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study.
López-Campos JL; Calero C; Rojano B; López-Porras M; Sáenz-Coronilla J; Blanco AI; Sánchez-López V; Tobar D; Montes-Worboys A; Arellano E
Int J Med Sci; 2013; 10(8):938-47. PubMed ID: 23801879
[TBL] [Abstract][Full Text] [Related]
13. Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis.
Lv F; Song LJ; Li XF
Int J Rheum Dis; 2015 Sep; 18(7):725-30. PubMed ID: 24131533
[TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
15. Reduced soluble receptor for advanced glycation end-products in COPD.
Smith DJ; Yerkovich ST; Towers MA; Carroll ML; Thomas R; Upham JW
Eur Respir J; 2011 Mar; 37(3):516-22. PubMed ID: 20595148
[TBL] [Abstract][Full Text] [Related]
16. Acute Phase Reactants: Relevance in Dermatology.
Jishna P; Dominic S
Indian Dermatol Online J; 2023; 14(1):1-8. PubMed ID: 36776186
[TBL] [Abstract][Full Text] [Related]
17. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
Higashimoto Y; Yamagata Y; Taya S; Iwata T; Okada M; Ishiguchi T; Sato H; Itoh H
Respirology; 2008 Jan; 13(1):128-33. PubMed ID: 18197923
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
[TBL] [Abstract][Full Text] [Related]
20. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
Dentener MA; Creutzberg EC; Pennings HJ; Rijkers GT; Mercken E; Wouters EF
Respiration; 2008; 76(3):275-82. PubMed ID: 18277064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
